In today’s episode, Chad sits down with guest scientist, Dr. Laura Sepp-Lorenzino the Chief Scientific Officer at Intellia Therapeutics. Laura is an innovative leader in drug discovery and the development of small molecules and nucleotide therapeutics. Pharma is in Laura’s blood as her mother, a pharmacist, encouraged her to pursue a career in the science. She shares how she went from studying biochemistry in Argentina and her pursuit of a Ph.D., then pivoting in a life-changing move to the United States. She also talks about the importance of paying it forward as a mentor, how gene therapy can prevent diseases, gene editing at Intellia Therapeutics, debunking stigmas behind vaccines, revisiting the Rubik’s Cube, and joining a debate club!

CEO of BioAgilytix Davide Molho, Discusses Passion, Innovation, and the Future of the CRO Industry
41:34

Drs. Shashank Gorityala, Ben Nie, and Amanda Hays talk LC/MS bioanalysis, platforms, matrices, workflows, and regulations.
46:24

Adam Stasio Talks, Large Data Sets, Breaking Down Problems, and Tech-Driven Solutions
41:00